BG28699A3 - Метод за получаване на алкилендиаминови производни - Google Patents

Метод за получаване на алкилендиаминови производни

Info

Publication number
BG28699A3
BG28699A3 BG039701A BG3970178A BG28699A3 BG 28699 A3 BG28699 A3 BG 28699A3 BG 039701 A BG039701 A BG 039701A BG 3970178 A BG3970178 A BG 3970178A BG 28699 A3 BG28699 A3 BG 28699A3
Authority
BG
Bulgaria
Prior art keywords
derivatives
alkylendiamine
obtaining
proven
formulated
Prior art date
Application number
BG039701A
Other languages
English (en)
Inventor
Thomas Raabe
Otto Graewinger
Josef Scholtholt
Echard Schraven
Original Assignee
Cassella Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Ag filed Critical Cassella Ag
Publication of BG28699A3 publication Critical patent/BG28699A3/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Метод за получаване на охарактеризирани и доказани в описанието алкилендиаминови производни с формула.... Патентните претенции са формулирани в 10 точки.
BG039701A 1977-05-16 1978-05-09 Метод за получаване на алкилендиаминови производни BG28699A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77339A LU77339A1 (bg) 1977-05-16 1977-05-16

Publications (1)

Publication Number Publication Date
BG28699A3 true BG28699A3 (bg) 1980-06-16

Family

ID=19728575

Family Applications (2)

Application Number Title Priority Date Filing Date
BG039702A BG28700A3 (bg) 1977-05-16 1978-05-09 Метод за получаване на алкилендиаминови производни
BG039701A BG28699A3 (bg) 1977-05-16 1978-05-09 Метод за получаване на алкилендиаминови производни

Family Applications Before (1)

Application Number Title Priority Date Filing Date
BG039702A BG28700A3 (bg) 1977-05-16 1978-05-09 Метод за получаване на алкилендиаминови производни

Country Status (30)

Country Link
US (1) US4216314A (bg)
JP (1) JPS53141285A (bg)
AR (1) AR224251A1 (bg)
AT (2) AT359523B (bg)
AU (1) AU3610578A (bg)
BE (1) BE867116A (bg)
BG (2) BG28700A3 (bg)
CA (1) CA1085842A (bg)
CS (1) CS203005B2 (bg)
DD (1) DD135489A5 (bg)
DE (1) DE2819629A1 (bg)
DK (1) DK203078A (bg)
EG (1) EG13302A (bg)
ES (1) ES469895A1 (bg)
FI (1) FI781461A (bg)
FR (1) FR2391199A1 (bg)
GB (1) GB1583428A (bg)
GR (1) GR71668B (bg)
IE (1) IE46895B1 (bg)
IT (1) IT1158712B (bg)
LU (1) LU77339A1 (bg)
NL (1) NL7804966A (bg)
NO (1) NO781635L (bg)
NZ (1) NZ187272A (bg)
PL (2) PL113674B1 (bg)
PT (1) PT68044B (bg)
RO (1) RO75870A (bg)
SE (1) SE7805260L (bg)
SU (2) SU793389A3 (bg)
ZA (1) ZA782758B (bg)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3023369A1 (de) * 1980-06-23 1982-01-14 Boehringer Mannheim Gmbh, 6800 Mannheim Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3048487A1 (de) * 1980-12-22 1982-07-29 Cassella Ag, 6000 Frankfurt Basisch substituierte pyridazine, ihre herstellung und ihre verwendung
DE3131146A1 (de) * 1981-08-06 1983-02-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue heteroaryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS59225170A (ja) * 1983-06-07 1984-12-18 Mitsui Toatsu Chem Inc アミノプロパノ−ル誘導体、その製造法、および該化合物を含有する心臓選択性β−アドレナリン作用遮断剤
JPH0637479B2 (ja) * 1987-12-28 1994-05-18 三井東圧化学株式会社 新規ピリミジン誘導体、その製造法およびそれを含有する抗不整脈剤
US5008267A (en) * 1988-10-29 1991-04-16 Mitsui Toatsu Chemicals, Incorporated Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same
US5308848A (en) * 1989-10-24 1994-05-03 Mitsui Toatsu Chemicals, Incorporated Pyrimidinedione derivatives and antiarrythmic agents containing the same
JP2815218B2 (ja) * 1990-04-13 1998-10-27 三井化学株式会社 ピリミジンジオン誘導体、およびそれを含有する抗不整脈剤
JPH03173885A (ja) * 1989-12-01 1991-07-29 Mitsui Toatsu Chem Inc ピリミジンジオン誘導体化合物、該化合物の製造法および該化合物を含む抗不整脈剤
JPH0413669A (ja) * 1990-04-27 1992-01-17 Mitsui Toatsu Chem Inc 新規ピリミジンジオン誘導体及び該化合物を含有する抗不整脈剤
DE4035599A1 (de) * 1990-11-06 1992-05-07 Dresden Arzneimittel Neue 5-(phenoxyalkanoylamino)-uracile, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE60238756D1 (de) 2001-05-11 2011-02-10 Endo Pharmaceuticals Inc Opioid enthaltende arzneiform gegen missbrauch
DE20308437U1 (de) 2002-04-05 2003-11-13 Euroceltique S.A., Luxemburg/Luxembourg Matrix zur verzögerten, gleichbleibenden und unabhängigen Freisetzung von Wirkstoffen
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
PT2405915T (pt) 2009-03-10 2019-01-29 Euro Celtique Sa Composições farmacêuticas de libertação imediata compreendendo oxicodona e naloxona
NZ716267A (en) 2013-07-23 2017-05-26 Euro Celtique Sa A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787103A (fr) * 1971-08-04 1973-02-02 Pfizer Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
US4020071A (en) * 1973-12-20 1977-04-26 Cassella Farbwerke Mainkur Aktiengesellschaft Derivatives of 1-phenoxy-3-amino-propan-2-ol

Also Published As

Publication number Publication date
LU77339A1 (bg) 1979-01-19
PT68044A (de) 1978-06-01
JPS53141285A (en) 1978-12-08
CS203005B2 (en) 1981-02-27
PT68044B (de) 1979-10-24
ZA782758B (en) 1979-05-30
NO781635L (no) 1978-11-17
IE46895B1 (en) 1983-10-19
PL113674B1 (en) 1980-12-31
AT359522B (de) 1980-11-10
DE2819629A1 (de) 1978-11-30
IT1158712B (it) 1987-02-25
FR2391199A1 (fr) 1978-12-15
BE867116A (fr) 1978-11-16
EG13302A (en) 1983-09-30
ATA343078A (de) 1980-04-15
IE780971L (en) 1978-11-16
DK203078A (da) 1978-11-17
AU3610578A (en) 1979-11-22
FI781461A (fi) 1978-11-17
PL206810A1 (pl) 1979-04-09
PL113762B1 (en) 1980-12-31
GR71668B (bg) 1983-06-20
AT359523B (de) 1980-11-10
DD135489A5 (de) 1979-05-09
ATA342978A (de) 1980-04-15
GB1583428A (en) 1981-01-28
RO75870A (ro) 1982-12-06
NL7804966A (nl) 1978-11-20
SU793389A3 (ru) 1980-12-30
US4216314A (en) 1980-08-05
FR2391199B1 (bg) 1981-07-24
AR224251A1 (es) 1981-11-13
ES469895A1 (es) 1979-09-16
NZ187272A (en) 1979-12-11
IT7823416A0 (it) 1978-05-15
BG28700A3 (bg) 1980-06-16
SU841587A3 (ru) 1981-06-23
SE7805260L (sv) 1978-11-17
CA1085842A (en) 1980-09-16

Similar Documents

Publication Publication Date Title
BG31225A3 (bg) Метод за получаване на ациланилидни производни
BG28065A4 (bg) Метод за получаване на 2-фенил-3-арилбензотиофели
BG31645A3 (bg) Метод за получаване на фенетаноламини
BG34338A3 (bg) Метод за получаване на тиадиазолилцефалоспорини
BG31499A3 (bg) Метод за получаване на 1-винилтриазолови производни
BG33294A3 (bg) Метод за получаване на антитуморни производни на 4-дезацетил vlвс-3 карбоксхидразид
BG36044A3 (bg) Метод за получаване на пиперазинови производни
BG27905A3 (bg) Метод за получаване на фосфонисти киселини
BG28699A3 (bg) Метод за получаване на алкилендиаминови производни
BG28072A4 (bg) Метод за получаване на 1 n заместени канамицинови производни
BG31224A3 (bg) Метод за получаване на производни на енкефалина
BG28573A3 (bg) Метод за получаване на аминоалкоксифенилови производни
BG30778A3 (bg) Метод за получаване на ебурнаменинови производни
BG34038A3 (bg) Метод за получаване на 7-заместени амино-ацетамидо оксадетиа-цефалоспорини
BG30175A4 (bg) Метод за получаване на пиридонови съединения
BG30021A3 (bg) Метод за получаване на имидазоизохинолин-диони
BG28565A3 (bg) Метод за получаване на пиролхиноксалинони и пиролбензодиазепинони
BG28574A3 (bg) Метод за получаване на 4 дифенилметилен 1 хидрокси бензол пиперидини
BG32116A3 (bg) Метод за получаване на 4''-амино-олеандомицинови производни
BG28845A3 (bg) Метод за получаване на n-алкилдифениламини
BG31947A3 (bg) Метод за получаване на ацетидинови производни
BG33283A3 (bg) Метод за получаване на пиридазинилхидразони
BG28066A3 (bg) Метод за получаване на пиридобензодиазепинони
BG29284A3 (bg) Метод за получаване на 3-ди-п пропилацетокси бензодиазепин-2-они
BG35035A3 (bg) Метод за получаване на нитроалканолови производни